Syk is required for monocyte/macrophage chemotaxis to CX3CL1 (fractalkine)

Journal of Immunology

Volumn 175, Issue 6, 2005, Pages 3737-3745

  Gevrey, Jean Claude ^a   Isaac, Beth M ^a   Cox, Dianne ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOTACTIC FACTOR; CX3CL1 CHEMOKINE; F ACTIN; FRACTALKINE; PROTEIN KINASE SYK; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BLOOD VESSEL INJURY; CELL MIGRATION; CELL STRUCTURE; CHEMOTAXIS; CONTROLLED STUDY; CYTOSKELETON; MACROPHAGE; MONOCYTE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 24744449505     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.6.3737     Document Type: Article

References (59)

1. Bazan, J. F., K. B. Bacon, G. Hardiman, W. Wang, K. Soo, D. Rossi, D. R. Greaves, A. Zlotnik, and T. J. Schall. 1997. A new class of membrane-bound chemokine with a CX3C motif. Nature 385: 640-644.
2. Pan, Y., C. Lloyd, H. Zhou, S. Dolich, J. Deeds, J. A. Gonzalo, J. Vath, M. Gosselin, J. Ma, B. Dussault, et al. 1997. Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature 387: 611-617.
3. Imai, T., K. Hieshima, C. Haskell, M. Baba, M. Nagira, M. Nishimura, M. Kakizaki, S. Takagi, H. Nomiyama, T. J. Schall, et al. 1997. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 91: 521-530.
4. Ruth, J. H., M. V. Volin, G. K. Haines III, D. C. Woodruff, K. J. Katschke, Jr., J. M. Woods, C. C. Park, J. C. Morel, and A. E. Koch. 2001. Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis. Arthritis Rheum. 44: 1568-1581.
5. Blaschke, S., M. Koziolek, A. Schwarz, P. Benohr, P. Middel, G. Schwarz, K. M. Hummel, and G. A. Muller. 2003. Proinflammatory role of fractalkine (CX3CL1) in rheumatoid arthritis. J. Rheumatol. 30: 1918-1927.
6. Nanki, T., Y. Urasaki, T. Imai, M. Nishimura, K. Muramoto, T. Kubota, and N. Miyasaka. 2004. Inhibition of fractalkine ameliorates murine collagen-induced arthritis. J. Immunol. 173: 7010-7016.
7. Moatti, D., S. Faure, F. Fumeron, W. Amara Mel, P. Seknadji, D. H. McDermott, P. Debre, M. C. Aumont, P. M. Murphy, D. de Prost, et al. 2001. Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease. Blood 97: 1925-1928.
8. -/- mice reveals a role for fractalkine in atherogenesis. J. Clin. Invest. 111: 333-340.
9. Combadiere, C., S. Potteaux, J. L. Gao, B. Esposito, S. Casanova, E. J. Lee, P. Debre, A. Tedgui, P. M. Murphy, and Z. Mallat. 2003. Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice. Circulation 107: 1009-1016.
10. McDermott, D. H., A. M. Fong, Q. Yang, J. M. Sechler, L. A. Cupples, M. N. Merrell, P. W. Wilson, R. B. D'Agostino, C. J. O'Donnell, D. D. Patel, et al. 2003. Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans. J. Clin. Invest. 111: 1241-1250.
11. Combien, B., M. Pomeranz, H. Schmid-Antomarchi, M. A. Millet, V. Breittmayer, B. Rossi, and A. Schmid-Alliana. 2001. Signal transduction pathways involved in soluble fractalkine-induced monocytic cell adhesion. Blood 97: 2031-2037.
12. Vitale, S., A. Schmid-Alliana, V. Breuil, M. Pomeranz, M. A. Millet, B. Rossi, and H. Schmid-Antomarchi. 2004. Soluble fractalkine prevents monocyte chemoattractant protein-1-induced monocyte migration via inhibition of stress-activated protein kinase 2/p38 and matrix metalloproteinase activities. J. Immunol. 172: 585-592.
13. Goda, S., T. Imai, O. Yoshie, O. Yoneda, H. Inoue, Y. Nagano, T. Okazaki, H. Imai, E. T. Bloom, N. Domae, et al. 2000. CX3C-chemokine, fractalkine-enhanced adhesion of THP-1 cells to endothelial cells through integrin-dependent and -independent mechanisms. J. Immunol. 164: 4313-4320.
14. Umehara, H., S. Goda, T. Imai, Y. Nagano, Y. Minami, Y. Tanaka, T. Okazaki, E. T. Bloom, and N. Domae. 2001. Fractalkine, a CX3C-chemokine, functions predominantly as an adhesion molecule in monocytic cell line THP-1. Immunol. Cell Biol. 79:298-302.
15. Chapman, G. A., K. E. Moores, J. Gohil, T. A. Berkhout, L. Patel, P. Green, C. H. Macphee, and B. R. Stewart. 2000. The role of fractalkine in the recruitment of monocytes to the endothelium. Eur. J. Pharmacol. 392: 189-195.
16. Tong, N., S. W. Perry, Q. Zhang, H. J. James, H. Guo, A. Brooks, H. Bal, S. A. Kinnear, S. Fine, L. G. Epstein, et al. 2000. Neuronal fractalkine expression in HIV-1 encephalitis: roles for macrophage recruitment and neuroprotection in the central nervous system. J. Immunol. 164: 1333-1339.
17. + monocytes. J. Exp. Med. 197: 1701-1707.
18. Cox, D., P. Chang, Q. Zhang, P. G. Reddy, G. M. Bokoch, and S. Greenberg. 1997. Requirements for both Rac1 and Cdc42 in membrane ruffling and phagocytosis in leukocytes. J. Exp. Med. 186: 1487-1494.
19. Stanley, E. R. 1997. Murine bone marrow-derived macrophages. Methods Mol. Biol. 75: 301-304.
20. Cox, D., P. Chang, T. Kurosaki, and S. Greenberg. 1996. Syk tyrosine kinase is required for immunoreceptor tyrosine activation motif-dependent actin assembly. J. Biol. Chem. 271: 16597-16602.
21. Bharti, A. C., Y. Takada, S. Shishodia, and B. B. Aggarwal. 2004. Evidence that receptor activator of nuclear factor (NF)-κB ligand can suppress cell proliferation and induce apoptosis through activation of a NF-κB-independent and TRAF6-dependent mechanism. J. Biol. Chem. 279: 6065-6076.
22. Lambert, L. E., and D. M. Paulnock. 1989. Differential induction of activation markers in macrophage cell lines by interferon-γ. Cell. Immunol. 120: 401-418.
23. Salh, B., R. Wagey, A. Marotta, J. S. Tao, and S. Pelech. 1998. Activation of phosphatidylinositol 3-kinase, protein kinase B, and p70 S6 kinases in lipopolysaccharide-stimulated Raw 264.7 cells: differential effects of rapamycin, Ly294002, and wortmannin on nitric oxide production. J. Immunol. 161: 6947-6954.
24. Bagga, D., L. Wang, R. Farias-Eisner, J. A. Glaspy, and S. T. Reddy. 2003. Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proc. Natl. Acad. Sci. USA 100: 1751-1756.
25. Raschke, W. C., S. Baird, P. Ralph, and I. Nakoinz. 1978. Functional macrophage cell lines transformed by Abelson leukemia virus. Cell 15: 261-267.
26. Larsen, E. C., T. Ueyama, P. M. Brannock, Y. Shirai, N. Saito, C. Larsson, D. Loegering, P. B. Weber, and M. R. Lennartz. 2002. A role for PKC-ε in Fc R-mediated phagocytosis by RAW 264.7 cells. J. Cell Biol. 159: 939-944.
27. Yu, X., Y. Huang, P. Collin-Osdoby, and P. Osdoby. 2003. Stromal cell-derived factor-1 (SDF-1) recruits osteoclast precursors by inducing chemotaxis, matrix metalloproteinase-9 (MMP-9) activity, and collagen transmigration. J. Bone Miner. Res. 18: 1404-1418.
28. Ridley, A. J., M. A. Schwartz, K. Burridge, R. A. Firtel, M. H. Ginsberg, G. Borisy, J. T. Parsons, and A. R. Horwitz. 2003. Cell migration: integrating signals from front to back. Science 302: 1704-1709.
29. Mellado, M., J. M. Rodriguez-Frade, S. Manes, and A. C. Martinez. 2001. Chemokine signaling and functional responses: the role of receptor dimerization and TK pathway activation. Annu. Rev. Immunol. 19: 397-421.
30. Zhang, J., M. L. Billingsley, R. L. Kincaid, and R. P. Siraganian. 2000. Phosphorylation of Syk activation loop tyrosines is essential for Syk function: an in vivo study using a specific anti-Syk activation loop phosphotyrosine antibody. J. Biol. Chem. 275: 35442-35447.
31. Crowley, M. T., P. S. Costello, C. J. Fitzer-Attas, M. Turner, F. Meng, C. Lowell, V. L. Tybulewicz, and A. L. DeFranco. 1997. A critical role for Syk in signal transduction and phagocytosis mediated by Fc receptors on macrophages. J. Exp. Med. 186: 1027-1039.
32. Pixley, F. J., and E. R. Stanley. 2004. CSF-1 regulation of the wandering macrophage: complexity in action. Trends Cell Biol. 14: 628-638.
33. Cambien, B., M. Pomeranz, M. A. Millet, B. Rossi, and A. Schmid-Alliana. 2001. Signal transduction involved in MCP-1-mediated monocytic transendothelial migration. Blood 97: 359-366.
34. 3CR1 reveals a role for fractalkine in cardiac allograft rejection. J. Clin. Invest. 108: 679-688.
35. Robinson, L. A., C. Nataraj, D. W. Thomas, D. N. Howell, R. Griffiths, V. Bautch, D. D. Patel, L. Feng, and T. M. Coffman. 2000. A role for fractalkine and its receptor (CX3CR1) in cardiac allograft rejection. J. Immunol. 165: 6067-6072.
36. Cockwell, P., S. J. Chakravorty, J. Girdlestone, and C. O. Savage. 2002. Fractalkine expression in human renal inflammation. J. Pathol. 196: 85-90.
37. + individuals with a structural variant of the chemokine receptor CX3CR1. Science 287: 2274-2277.
38. Foussat, A., L. Bouchet-Delbos, D. Berrebi, I. Durand-Gasselin, A. Coulomb-L'Hermine, R. Krzysiek, P. Galanaud, Y. Levy, and D. Emilie. 2001. Deregulation of the expression of the fractalkine/fractalkine receptor complex in HIV-1-infected patients. Blood 98: 1678-1686.
39. Umehara, H., E. T. Bloom, T. Okazaki, Y. Nagano, O. Yoshie, and T. Imai. 2004. Fractalkine in vascular biology: from basic research to clinical disease. Arterioscler. Thromb. Vasc. Biol. 24: 34-40.
40. Casarosa, P., R. A. Bakker, D. Verzijl, M. Navis, H. Timmerman, R. Leurs, and M. J. Smit. 2001. Constitutive signaling of the human cytomegalovirus- encoded chemokine receptor US28. J. Biol. Chem. 276: 1133-1137.
41. Shulby, S. A., N. G. Dolloff M. E. Stearns, O. Meucci, and A. Fatatis. 2004. CX3CR1-fractalkine expression regulates cellular mechanisms involved in adhesion, migration, and survival of human prostate cancer cells. Cancer Res. 64: 4693-4698.
42. Dichmann, S., Y. Herouy, D. Purlis, H. Rheinen, P. Gebicke-Harter, and J. Norgauer. 2001. Fractalkine induces chemotaxis and actin polymerization in human dendritic cells. Inflamm. Res. 50: 529-533.
43. Foussat, A., A. Coulomb-L'Hermine, J. Gosling, R. Krzysiek, I. Durand-Gasselin, T. Schall, A. Balian, Y. Richard, P. Galanaud, and D. Emilie. 2000. Fractalkine receptor expression by T lymphocyte subpopulations and in vivo production of fractalkine in human. Eur. J. Immunol. 30: 87-97.
44. Maciejewski-Lenoir, D., S. Chen, L. Feng, R. Maki, and K. B. Bacon. 1999. Characterization of fractalkine in rat brain cells: migratory and activation signals for CX3CR-l-expressing microglia. J. Immunol. 163: 1628-1635.
45. Turner, M., E. Schweighoffer, F. Colucci, J. P. Di Santo, and V. L. Tybulewicz. 2000. Tyrosine kinase SYK: essential functions for immunoreceptor signalling. Immunol. Today 21: 148-154.
46. Ottoson, N. C., J. T. Pribila, A. S. Chan, and Y. Shimizu. 2001. Cutting edge: T cell migration regulated by CXCR4 chemokine receptor signaling to ZAP-70 tyrosine kinase. J. Immunol. 167: 1857-1861.
47. Ticchioni, M., C. Charvet, N. Noraz, L. Lamy, M. Steinberg, A. Bernard, and M. Deckert. 2002. Signaling through ZAP-70 is required for CXCL12-mediated T-cell transendothelial migration. Blood 99: 3111-3118.
48. Ganju, R. K., S. A. Brubaker, R. D. Chernock, S. Avraham, and J. E. Groopman. 2000. β-Chemokine receptor CCR5 signals through SHP1, SHP2, and Syk. J. Biol. Chem. 275: 17263-17268.
49. + hemopoietic progenitors induced by granulocyte-macrophage colony-stimulating factor. II. Signaling pathways involved. J. Immunol. 167: 4405-4413.
50. 2 integrin receptor and Syk kinase signaling in monocytes by the Src family kinase Fgr. Immunity 15: 507-519.
51. syk and Src-related protein tyrosine kinases. Biochemistry 35: 5327-5332.
52. Uruno, T., P. Zhang, J. Liu, J. J. Hao, and X. Zhan. 2003. Haematopoietic lineage cell-specific protein 1 (HS1) promotes actin-related protein (Arp) 2/3 complex-mediated actin polymerization. Biochem. J. 371: 485-493.
53. Larbolette, O., B. Wollscheid, J. Schweikert, P. J. Nielsen, and J. Wienands. 1999. SH3P7 is a cytoskeleton adapter protein and is coupled to signal transduction from lymphocyte antigen receptors. Mol. Cell. Biol. 19: 1539-1546.
54. Hao, J. J., G. B. Carey, and X. Zhan. 2004. Syk-mediated tyrosine phosphorylation is required for the association of hematopoietic lineage cell-specific protein 1 with lipid rafts and B cell antigen receptor signalosome complex. J. Biol. Chem. 279: 33413-33420.
55. Oda, A., H. D. Ochs, L. A. Lasky, S. Spencer, K. Ozaki, M. Fujihara, M. Handa, K. Ikebuchi, and H. Ikeda. 2001. CrkL is an adapter for Wiskott-Aldrich syndrome protein and Syk. Blood 97: 2633-2639.
56. Kettner, A., L. Kumar, I. M. Anton, Y. Sasahara, M. de la Fuente, V. I. Pivniouk, H. Falet, J. H. Hartwig, and R. S. Geha. 2004. WIP regulates signaling via the high affinity receptor for immunoglobulin E in mast cells. J. Exp. Med. 199: 357-368.
57. Sasahara, Y., R. Rachid, M. J. Byrne, M. A. de la Fuente, R. T. Abraham, N. Ramesh, and R. S. Geha. 2002. Mechanism of recruitment of WASP to the immunological synapse and of its activation following TCR ligation. Mol. Cell 10: 1269-1281.
58. Mocsai, A., H. Zhang, Z. Jakus, J. Kitaura, T. Kawakami, and C. A. Lowell. 2003. G-protein-coupled receptor signaling in Syk-deficient neutrophils and mast cells. Blood 101: 4155-4163.
59. 2-terminal kinase activation in human neutrophils: role of phosphatidylinositol 3-kinase and Syk-mediated pathways. J. Biol. Chem. 279: 10883-10891.